Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons

AIDS Research and Human Retroviruses - United States
doi 10.1089/aid.2014.0284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Barriers to Treatment of Hepatitis C in HIV/HCV Coinfected Adults in Brazil

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2010English

Short Communication: Risk of Elevated Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio After Antiretroviral Therapy in HIV/Hepatitis C Virus Patients

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2012English

Interleukin-23 Promotes Interferon-Α Responsiveness in Hepatitis C Virus/HIV-Coinfected Patients

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2014English

Hepatitis C Virus Seroprevalence and Risk Factors Among Patients With HIV Infection

Revista do Instituto de Medicina Tropical de Sao Paulo
MedicineInfectious Diseases
2001English

Prediction of Coronary Heart Disease: A Comparison Between the Copenhagen Risk Score and the Framingham Risk Score Applied to a Dutch Population

Journal of Internal Medicine
Internal Medicine
2003English

Risk Factors for Hepatitis C Virus Infection in Canadian Patients With Chronic Type C Hepatitis

Canadian Journal of Gastroenterology
1995English

Risk Factors of Chronic Hepatitis in Antiretroviral-Treated HIV Infection, Without Hepatitis B or C Viral Infection

AIDS Research and Therapy
VirologyMolecular MedicinePharmacology
2013English

Hepatitis C Virus and Death Risk in Hemodialysis Patients

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2007English

Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy